PMC:7301188 / 13711-14034
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T105 | 257-273 | GO:0050817 | denotes | hypercoagulating |
| T103 | 197-208 | GO:0050817 | denotes | coagulating |
| T104 | 234-242 | SP_7 | denotes | COVID-19 |
| T106 | 310-322 | GO:0042730 | denotes | fibrinolysis |
| T34057 | 197-208 | GO:0050817 | denotes | coagulating |
| T54071 | 234-242 | SP_7 | denotes | COVID-19 |
| T87943 | 257-273 | GO:0050817 | denotes | hypercoagulating |
| T67612 | 310-322 | GO:0042730 | denotes | fibrinolysis |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 340 | 99-101 | Gene | denotes | Fg | Gene:2244 |
| 341 | 220-228 | Species | denotes | patients | Tax:9606 |
| 345 | 234-242 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T116 | 234-242 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T113 | 296-306 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T79 | 51-53 | Chemical | denotes | PT | http://purl.obolibrary.org/obo/CHEBI_141395 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 296-322 | http://purl.obolibrary.org/obo/GO_0051919 | denotes | activation of fibrinolysis |
| T20 | 310-322 | http://purl.obolibrary.org/obo/GO_0042730 | denotes | fibrinolysis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T130 | 0-323 | Sentence | denotes | Based on the study results, the levels of D-dimer, PT, and APTT were significantly higher, whereas Fg in deceased cases was significantly lower than those in survival cases, suggesting the dynamic coagulating process in patients with COVID-19 is likely the hypercoagulating state followed by the activation of fibrinolysis. |